Editorial: Pharmacoinformatics: new developments and challenges in drug design
- PMID: 39139636
- PMCID: PMC11319297
- DOI: 10.3389/fphar.2024.1462070
Editorial: Pharmacoinformatics: new developments and challenges in drug design
Keywords: drug design; multi target directed ligand; pharmacoinformatics; pharmacology; systems pharmacology.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Pharmacoinformatics: new developments and challenges in drug design
Similar articles
-
Key Elements of Pharmacoinformatics for the Degrees of Bachelor and Master of Pharmacy.Ther Innov Regul Sci. 2017 Jul;51(4):419-425. doi: 10.1177/2168479017701977. Epub 2017 Apr 7. Ther Innov Regul Sci. 2017. PMID: 30227049
-
Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy.Lancet Oncol. 2009 Oct;10(10):1011-9. doi: 10.1016/S1470-2045(09)70104-4. Lancet Oncol. 2009. PMID: 19796753 Review.
-
[Pharmacoinformatics and pharmacogenomics].Nihon Yakurigaku Zasshi. 2005 Aug;126(2):113-6. doi: 10.1254/fpj.126.113. Nihon Yakurigaku Zasshi. 2005. PMID: 16205013 Review. Japanese. No abstract available.
-
A super-combo-drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy.Stat Med. 2020 May 15;39(10):1458-1472. doi: 10.1002/sim.8490. Epub 2020 Feb 26. Stat Med. 2020. PMID: 32101641 Free PMC article.
-
Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18.Drug Des Devel Ther. 2014 May 21;8:571-81. doi: 10.2147/DDDT.S63096. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24899801 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources